June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Functional assessment of putative splice-altering variants detected in an Irish inherited retinal disease cohort
Author Affiliations & Notes
  • Ciara Shortall
    School of Genetics and Microbiology, The University of Dublin Trinity College, Dublin, Ireland
  • Laura Whelan
    School of Genetics and Microbiology, The University of Dublin Trinity College, Dublin, Ireland
  • Ella Kopcic
    School of Genetics and Microbiology, The University of Dublin Trinity College, Dublin, Ireland
  • Adrian Dockery
    School of Genetics and Microbiology, The University of Dublin Trinity College, Dublin, Ireland
    Pathology Department, Mater Misericordiae University Hospital, Dublin, Ireland
  • Emma Duignan
    Department of Ophthalmology, Royal Victoria Eye and Ear Hospital, Dublin, Ireland
  • Niamh Wynne
    Department of Ophthalmology, Royal Victoria Eye and Ear Hospital, Dublin, Ireland
  • Julia Zhu
    Clinical Genetics Centre for Ophthalmology, Mater Misericordiae University Hospital, Dublin, Ireland
  • Kirk A.J. Stephenson
    Clinical Genetics Centre for Ophthalmology, Mater Misericordiae University Hospital, Dublin, Ireland
  • Claire Kirk
    Department of Ophthalmology, Royal Victoria Hospital, Belfast, Belfast, United Kingdom
    Centre for Experimental Medicine, Queen's University Belfast, Belfast, Belfast, United Kingdom
  • Jacqueline Turner
    Clinical Genetics Centre for Ophthalmology, Mater Misericordiae University Hospital, Dublin, Ireland
  • James J O'Byrne
    Clinical Genetics Centre for Ophthalmology, Mater Misericordiae University Hospital, Dublin, Ireland
  • Giuliana Silvestri
    Department of Ophthalmology, Royal Victoria Hospital, Belfast, Belfast, United Kingdom
    Centre for Experimental Medicine, Queen's University Belfast, Belfast, Belfast, United Kingdom
  • David J Keegan
    Clinical Genetics Centre for Ophthalmology, Mater Misericordiae University Hospital, Dublin, Ireland
  • Paul F Kenna
    School of Genetics and Microbiology, The University of Dublin Trinity College, Dublin, Ireland
    Department of Ophthalmology, Royal Victoria Eye and Ear Hospital, Dublin, Ireland
  • G.Jane Farrar
    School of Genetics and Microbiology, The University of Dublin Trinity College, Dublin, Ireland
  • Footnotes
    Commercial Relationships   Ciara Shortall None; Laura Whelan None; Ella Kopcic None; Adrian Dockery None; Emma Duignan None; Niamh Wynne None; Julia Zhu None; Kirk Stephenson None; Claire Kirk None; Jacqueline Turner None; James O'Byrne None; Giuliana Silvestri None; David Keegan None; Paul Kenna None; G.Jane Farrar None
  • Footnotes
    Support  Fighting Blindness Ireland (FB18CRE, FB20DOC); Health Research Charities Ireland/ Fighting Blindness Ireland/ Health Research Board (MRCG-2016-14, HRCI-2020-007); Science Foundation Ireland (16/IA/4452)
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 1598 – A0387. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ciara Shortall, Laura Whelan, Ella Kopcic, Adrian Dockery, Emma Duignan, Niamh Wynne, Julia Zhu, Kirk A.J. Stephenson, Claire Kirk, Jacqueline Turner, James J O'Byrne, Giuliana Silvestri, David J Keegan, Paul F Kenna, G.Jane Farrar; Functional assessment of putative splice-altering variants detected in an Irish inherited retinal disease cohort. Invest. Ophthalmol. Vis. Sci. 2022;63(7):1598 – A0387.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Aberrant RNA splicing has emerged as a significant cause of inherited retinal diseases (IRDs). Next generation sequencing of IRD patients living in Ireland and utilisation of in silico splice prediction tools have enabled identification of putative splice-altering variants in IRD-associated genes. The aim of this study was to experimentally validate several of these variants using in vitro splice assays.

Methods : Probands underwent target capture sequencing of exons and canonical/noncanonical splice site regions of 254 IRD-associated genes. Putative splice-altering variants were identified and prioritised for further analysis using in silico splice prediction tools, including SpliceAI and Alamut Visual software. Genomic segments containing the variant of interest or wild-type sequence and flanking exons were amplified, cloned into midigene plasmid vectors and transfected into HEK 293 cells. mRNA was isolated 48 hours post-transfection and transcripts were analysed via RT-PCR, gel electrophoresis and Sanger sequencing.

Results : Midigene splice assays were used to evaluate the consequences of OPA1 c.1681+1G>T (NM_130837.2) and FLVCR1 c.1307+5G>T (NM_014053.3), as well as previously unreported variants in TULP1 (NM_003322.4:c.999+5G>T) and CACNA1F (NM_005183.3: c.2576+4_2576+5delAG). Transfection of a wild-type OPA1 midigene resulted in a single mRNA product of expected length while the mutant construct exclusively produced a shorter fragment in which exon 17 was skipped, leading to a frameshift (p.Ile537Glyfs*10). A wild-type FLVCR1 midigene yielded a full-length transcript and an additional product lacking exon 6. In contrast, the mutant FLVCR1 midigene did not produce any detectable full-length transcript and appeared to increase skipping of exon 6, which causes an in-frame deletion of 37 amino acids. The novel TULP1 and CACNA1F variants tested appeared to induce complex aberrant splicing patterns and work is underway to elucidate the precise nature of these defects.

Conclusions : This study characterised splicing defects resulting from canonical and noncanonical splice site mutations in IRD-associated genes – providing new evidence in support of variant pathogenicity. Functional analysis of such variants is vital for accurate classification of pathogenicity and severity, and increasingly important for enabling access to emerging gene therapies.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×